These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 10090138)

  • 1. High prevalence of thyroid dysfunction in adult patients with beta-thalassemia major submitted to amiodarone treatment.
    Mariotti S; Loviselli A; Murenu S; Sau F; Valentino L; Mandas A; Vacquer S; Martino E; Balestrieri A; Lai ME
    J Endocrinol Invest; 1999 Jan; 22(1):55-63. PubMed ID: 10090138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic particularities in amiodarone induced thyroid disorder in patients with underlying cardiac condition.
    Costache L; Mogos V; Preda C; Vulpoi C; Ungureanu MC
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):959-64. PubMed ID: 25581954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.
    Sato K; Miyakawa M; Eto M; Inaba T; Matsuda N; Shiga T; Ohnishi S; Kasanuki H
    Endocr J; 1999 Jun; 46(3):443-51. PubMed ID: 10503998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amiodarone-associated thyroid dysfunction: prevalence and possibilities of correction].
    Serdiuk SE; Bakalov SA; Soboleva VA; Golitsin SP; Molashenko NV; Platonova NM; Sviridenko NIu
    Kardiologiia; 2004; 44(10):32-8. PubMed ID: 15477787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical value of regular thyroid function tests during amiodarone treatment.
    Benjamens S; Dullaart RPF; Sluiter WJ; Rienstra M; van Gelder IC; Links TP
    Eur J Endocrinol; 2017 Jul; 177(1):9-14. PubMed ID: 28424174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation.
    Batcher EL; Tang XC; Singh BN; Singh SN; Reda DJ; Hershman JM;
    Am J Med; 2007 Oct; 120(10):880-5. PubMed ID: 17904459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone-induced thyroid dysfunction in the Hong Kong Chinese population.
    Lee KF; Lee KM; Fung TT
    Hong Kong Med J; 2010 Dec; 16(6):434-9. PubMed ID: 21135419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects of amiodarone on the thyroid].
    Toni M; Anda E; Pineda J; Martínez de Esteban JP; Ollero MD
    An Sist Sanit Navar; 2009; 32(3):363-70. PubMed ID: 20094097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism: the subsequent phases of thyroid function in a patient chronically treated with amiodarone.
    Minelli R; Gardini E; Bianconi L; Salvi M; Roti E
    J Endocrinol Invest; 1992 Dec; 15(11):853-5. PubMed ID: 1291598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thyroid dysfunction in long-term amiodarone administration. Correlation of the antiarrhythmic activity of amiodarone with its effect on thyroid function].
    Serdiuk SE; Bakalov SA; Golitsyn SP; Sitina VK; Molashenko NV; Platonova NM; Sviridenko NIu
    Kardiologiia; 2005; 45(1):22-7. PubMed ID: 15699935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.
    Trifănescu R; Fica S; Barbu C; Vârtej I; Ursu H; Bunghez R; Coculescu M
    Rom J Intern Med; 2004; 42(3):595-605. PubMed ID: 16366133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism.
    Hofmann A; Nawara C; Ofluoglu S; Holzmannhofer J; Strohmer B; Pirich C
    Wien Klin Wochenschr; 2008; 120(15-16):493-8. PubMed ID: 18820854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amiodarone and thyroid dysfunction: a pending problem].
    Perazza L; Scardi S
    Monaldi Arch Chest Dis; 2003 Sep; 60(3):235-9. PubMed ID: 14650817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of amiodarone-associated thyrotoxicosis.
    Franklyn JA; Gammage MD
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):662-6. PubMed ID: 17710087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of amiodarone-induced thyrotoxicosis and hypothyroidism].
    Gerber H; Noth D
    Ther Umsch; 1999 Jul; 56(7):374-9. PubMed ID: 10434774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring thyroid function during amiodarone use.
    Sharma P; Sheikh R; Siribaddana N; Sathyanarayanan A; Fernando D; Muraleedharan V
    Br J Hosp Med (Lond); 2024 Jan; 85(1):1-5. PubMed ID: 38300678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants and outcome of amiodarone-associated thyroid dysfunction.
    Ahmed S; Van Gelder IC; Wiesfeld AC; Van Veldhuisen DJ; Links TP
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):388-94. PubMed ID: 21535072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of amiodaron on the thyroid function].
    Kucharczyk P; Michałkiewicz D; Kucharczyk A
    Pol Merkur Lekarski; 2006 Jul; 21(121):86-9. PubMed ID: 17007301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amiodarone and the thyroid gland].
    Bednarek-Tupikowska G; Filus A; Kuliczkowska J; Bugajski J
    Postepy Hig Med Dosw (Online); 2004 Apr; 58():216-25. PubMed ID: 15114257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of amiodarone therapy on thyroid function.
    Cohen-Lehman J; Dahl P; Danzi S; Klein I
    Nat Rev Endocrinol; 2010 Jan; 6(1):34-41. PubMed ID: 19935743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.